Following the COVID crisis, there are significant numbers of patients with type 2 diabetes who would benefit from clinical reviews. The ECLPISE system has improved and patients requiring review can more easily be identified and risk stratified with less clinician time than previously required to achieve this.
ECLIPSE is widely available and can save significant amounts of time when used well. This session will update practice staff and clinicians on new functionality and support more efficient use of resources